77351

Integrative MS, NMR and in silico approach for screening acetylcholinesterase inhibitory alkaloids from Onychopetalum amazonicum (Annonaceae)

Favorite this paper

Integrative MS, NMR and in silico approach for screening acetylcholinesterase inhibitory alkaloids from Onychopetalum amazonicum (Annonaceae)

Bruna R. de Limaa*, Felipe M. A. da Silvaa, Elzalina R. Soaresa, Richardson A. de Almeidaa,Francinaldo A. da Silva Filhoa, , Lívia M. Dutrab, Andersson Barisonb,Hector H. F. Koolenc, Afonso D. L. de Souzaa, Maria L. B. Pinheiroa.
aDepartment of Chemistry, Federal University of Amazonas, 69077-000, Manaus-AM, Brazil.bNMR Center, Federal Universisty of Parana, 81531-990, Curitiba, PR,, Brazil. cDeMpSter Mass Spectrometry Group, Amazonas State University, 69055-010, Manaus, AM, Brazil.*[email protected]

The small Onychopetalum genus belongs to an informal botanic group whose species are used in traditional medicine to treat age related cognitive disorder [1-2]. Chemical studies point these genera as promising sources of isoquinoline-derived alkaloids [3-5]. The species O. amazonicum (R.E.Fr), popularly known as envira preta and envira caju, occurs in non-inundated forestand is distributed in the Brazilian Amazon region (Amazonas, Mato Grosso, Pará and Rondônia) and Venezuela (Amazonas)[1]. In order to screening acetylcholinesterase inhibitory alkaloids from Onychopetalum amazonicum, an integrative approach based on the chemical profile analysis by leaf spray mass spectrometry (LS-MS), followed by robust dereplication through UHPLC- DAD-MS/MS and 2D NMR, and molecular docking was performed. The isoquinoline-derived alkaloids nornuciferine, anonaine, asimilobine, O-methylisopiline, isocorypalmine, stepholidine and norjuziphine were characterized. Molecular docking has revealed hypothetical binding modes between the most active compounds In silico (nornuciferine 1 and asimilobine 2) and the acetylcholinesterase enzyme (AChE), supporting previous pharmacological studies regarding alkaloids with acetycholinesterase inhibitory potential [6].

[1] MAAS, P.J.M., et al. Blumea52, 413-554, 2007.
[2] ADAMS, M., et al. J. Ethnopharmacol.113, 363-381, 2007.
[3]SOARES, E. R.,et al. Phytochem. Anal.26,339-345, 2015.
[4] SILVA, F. M. A., et al. Quím. Nova35, 944-947, 2012.
[5] SILVA, F. M. A., et al. Phytochem. Anal.25, 45-49, 2014.
[6] SRAMEK, J.J., et al. Exp. Opin. Invest. Drugs 9, 2393-2402, 2000.